New RSV vaccine data could boost Novavax as it searches for pathway to market

A new analysis of the company ’s phase 3 study for ResVax shows the candidate effectively diminished pneumonia cases in infants tied to RSV, a respiratory illness in newborns.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 13, 2019 Category: Pharmaceuticals Authors: Sara Gilgore Source Type: news